Showing 1-5 of about 5 articles.
Research and Markets
Dublin, Aug. 17, 2020 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. The Global Peptide Therapeutics...
Lexicon Pharmaceuticals, Inc.; Ipsen Biopharmaceuticals Canada Inc.
Approval Enables Availability of First-in-Class Oral Tryptophan Hydroxylase Inhibitor that Sustains Improvement of Carcinoid Syndrome Diarrhea in Adults Inadequately Controlled by Somatostatin Analogs...
Ipsen Biopharmaceuticals Canada Inc.
MISSISSAUGA, ON--(Marketwired - 9 janvier 2018) - Ipsen Biopharmaceuticals Canada Inc., la filiale canadienne d'Ipsen (EURONEXT PARIS: IPN) (ADR: IPSEY), a annoncé aujourd'hui que Santé Canada a...
Ipsen Biopharmaceuticals Canada Inc.
MISSISSAUGA, ON--(Marketwired - January 09, 2018) - Ipsen Biopharmaceuticals Canada Inc., the Canadian affiliate of Ipsen (EURONEXT PARIS: IPN) (ADR: IPSEY) today announced that Health Canada has...
Zion Market Research
Sarasota, FL, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Acromegaly Treatment Market by Disease Type (Ectopic Acromegaly and Pseudo Acromegaly), By...
Showing 1-5 of about 5 articles.
